Commercial Influenza Diagnostic Test Discrepant Results Reporting Tool

Español | Other Languages

Commercially available influenza diagnostic tests are commonly used by clinicians and hospital laboratories to detect influenza viruses in patients exhibiting symptoms of respiratory illness. Due to periodic reports of inaccurate results (i.e. false positive or false negative results) using rapid influenza diagnostic tests (RIDT) and commercial molecular tests, there is a concern for a potentially negative impact on public health/clinical management. The CDC/Influenza Division is requesting that public health laboratories notify CDC of incidents were discrepant results are observed in order to monitor if a particular diagnostic test is performing inaccurately.

Note: Fields marked with a (*) are mandatory

Public Health Reporting Laboratory Information:

*Laboratory Name:

*Street Address (Please give correct shipping/receiving address):

Street Address (continued, optional):

*City:

*State:

*Postal Code:

*Prefix:

*Title / Rank:

*First Name:

*Last Name:

*Laboratory Phone:

*Laboratory Email:

Commercial Influenza Diagnostic Testing Facility Information:

Facility Name:

Facility Type:

Street Address (Please give correct shipping/receiving address):

Street Address (continued, optional):

City:

State:

Postal Code:

Rapid Influenza Diagnostic Test Result:

Manufacturer

Test Name

Lot #

Test Result

Test Date

Molecular Influenza Diagnostic Test Result:

Manufacturer

Test Name

Lot #

Test Result

Test Date

CDC Flu RT-PCR Dx Panel:

CDC Flu Dr-PCR Dx Panel Test Results
(indicate Ct values obtained for each assay tested; NT= not tested, 0= tested with not Ct value)

Date Tested

InfA

pdm InfA

pdm H1

InfB

B-Vic

B-Yam

Result

Comments:

Page last reviewed: April 19, 2017

Content source: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)